Evidence map›Paper›PMID 17163490›Full record

ArticleJournal of cellular biochemistry2007

Smooth muscle alpha-actin expression and myofibroblast differentiation by TGFbeta are dependent upon MK2.

Anne Marie Sousa, Tiegang Liu, Oscar Guevara, Joanne Stevens, Barry L Fanburg, Matthias Gaestel, Deniz Toksoz, Usamah S Kayyali

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular biochemistry, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Transcriptomics ofMicroorganisms · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Anne Marie SousaPulmonary and Critical Care Division, Department of Medicine/Tupper Research Institute, Tufts-New England Medical Center, and Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
Tiegang Liu
Oscar Guevara
Joanne Stevens
Barry L Fanburg
Matthias Gaestel
Deniz Toksoz
Usamah S Kayyali
Tufts University · USTufts Medical Center · USMedizinische Hochschule Hannover · DE

Funding

Hypoxia-induced Endothelial Barrier DysfunctionR01HL079320 · NHLBI · TUFTS MEDICAL CENTER · PI KAYYALI, USAMAH S · 2005 to 2009
$1.9M
NHLBI NIH HHS HL079320NHLBI NIH HHS R01 HL079320
6 · The paper itself

Abstract

Fibroblasts play a major role in processes such as wound repair, scarring, and fibrosis. Differentiation into myofibroblasts, characterized by upregulation of smooth muscle alpha-actin (smalpha) in response to profibrotic agents such as TGFbeta is believed to be an important step in fibrosis. Therefore, elucidating mechanisms of myofibroblast differentiation might reveal novel targets in treating diseases such as idiopathic pulmonary fibrosis (IPF). MK2 is a kinase substrate of p38 MAP kinase that mediates some effects of p38 activation on the actin cytoskeleton. Using mouse embryonic fibroblasts (MEF) from MK2 knockout (MK2(-/-)) mice, we demonstrate that disrupting expression of MK2 expression reduces filamentous actin and stress fibers. It also causes MK2(-/-) MEF to express less smalpha than their corresponding wild-type (WT) MEF at baseline and in response to TGFbeta. Furthermore, TGFbeta causes downregulation of smalpha in MK2(-/-) MEF, instead of upregulation observed in WT MEF. Expression of other fibroblast markers, such as collagen, is not altered in MK2(-/-) MEF. Our results further suggest that downregulation of smalpha in MK2(-/-) MEF is not due to lack of activation of serum responsive promoter elements, but probably due to reduced smalpha message stability in these cells. These results indicate that MK2 plays a key role in regulation of smalpha expression, and that targeting MK2 might present a therapeutic approach in managing conditions such as pulmonary fibrosis.

Indexed as

ActinsAnimalsCell DifferentiationCells, CulturedElectrophoresis, Polyacrylamide GelFibroblastsGene ExpressionImidazolesImmunoblottingIntracellular Signaling Peptides and ProteinsLuciferasesMAP-Kinase-Activated Kinase 2MiceMice, Inbred C57BLMice, KnockoutMuscle, SmoothActinsImidazolesIntracellular Signaling Peptides and ProteinsLuciferasesMAP-Kinase-Activated Kinase 2p38 Mitogen-Activated Protein KinasesProtein KinasesProtein Serine-Threonine KinasesPyridinesRecombinant Fusion ProteinsRNA, MessengerSB 203580Transforming Growth Factor beta

Identifiers

PMID17163490
PMCPMC2586991
OpenAlexW2171177609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.